Argenx SE Files 6-K Report
Ticker: ARGX · Form: 6-K · Filed: Sep 19, 2024 · CIK: 1697862
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Argenx SE filed a 6-K on 9/19/24, standard foreign issuer report.
AI Summary
On September 19, 2024, argenx SE filed a Form 6-K, reporting its status as a foreign private issuer. The filing provides information regarding its principal executive offices located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands. argenx SE is incorporated in P7 and its fiscal year ends on December 31.
Why It Matters
This filing is a routine report for foreign private issuers, indicating ongoing compliance and providing basic corporate information to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain material new financial or operational information.
Key Players & Entities
- ARGENX SE (company) — Filer
- 001-38097 (company) — SEC File Number
- 241308764 (company) — Film Number
- September 19, 2024 (date) — Filing Date
- Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands (location) — Principal Executive Offices
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on September 19, 2024.
What is the SEC file number for ARGENX SE?
The SEC file number for ARGENX SE is 001-38097.
Where are ARGENX SE's principal executive offices located?
ARGENX SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
What is the fiscal year end for ARGENX SE?
ARGENX SE's fiscal year ends on December 31.
Filing Stats: 289 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-09-19 06:06:23
Filing Documents
- tm2424273d1_6k.htm (6-K) — 12KB
- tm2424273d1_ex99-1.htm (EX-99.1) — 25KB
- 0001104659-24-101148.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: September 19, 2024 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel